Clinical Trial Update: Treatment of Chronic Lymphocytic Leukemia in Patients Previously Exposed to Rituximab [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating treatment for chronic lymphocytic leukemia in patients who had previously received Rituximab, with results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Snippet

Sponsor: Medical University of South Carolina | Conditions: Chronic Lymphocytic Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2015-12-03